Literature DB >> 8180969

A novel ex vivo method for assaying adhesion of cancer cells to the peritoneum.

T Asao1, S Yazawa, S Kudo, S Takenoshita, Y Nagamachi.   

Abstract

A novel ex vivo method to determine the cell adhesion of cancer cells to the peritoneum was described. The wells of a microtiter plate were filled with cell suspension and sealed using mouse peritoneum. The peritoneum was fixed using a plastic cover and the plate was turned upside down and incubated for cell adhesion. After incubation for 80 min, the plate was centrifuged and non-adherent cells were assayed by MTT assay. Human cancer cells (MKN28, MKN45, MKN74, KM12C and KM12SM) adhered to the mouse peritoneum as well as cells from mouse (Colon26) and the ratio of cells attached to the peritoneum was estimated to be between 12.8 and 66.4%. This simple method could be useful to investigate the adhesion molecule associated with peritoneal dissemination.

Entities:  

Mesh:

Year:  1994        PMID: 8180969     DOI: 10.1016/0304-3835(94)90031-0

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  10 in total

1.  Study on incisional implantation of tumor cells by carbon dioxide pneumo peritoneum in gastric cancer of a murine model.

Authors:  Hao Wang; Min-Hua Zheng; Hao-Bo Zhang; Jian Zhu; Jian-Rong He; Ai-Guo Lu; Yu-Bao Ji; Min-Jun Zhang; Yu Jiang; Bao-Ming Yu; Hong-Wei Li
Journal:  World J Gastroenterol       Date:  1999-12       Impact factor: 5.742

2.  A new method for assaying adhesion of cancer cells to the greater omentum and its application for evaluating anti-adhesion activities of chemically synthesized oligosaccharides.

Authors:  A Okamura; S Yazawa; T Nishimura; S Tanaka; I Takai; S Kudo; T Asao; H Kuwano; K L Matta; S Akamatsu; N Kochibe
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis.

Authors:  Cristina Di Giorgio; Silvia Marchianò; Elisabetta Marino; Michele Biagioli; Rosalinda Roselli; Martina Bordoni; Rachele Bellini; Ginevra Urbani; Angela Zampella; Eleonora Distrutti; Annibale Donini; Luigina Graziosi; Stefano Fiorucci
Journal:  Front Oncol       Date:  2022-06-30       Impact factor: 5.738

Review 4.  Targeting cancer using cholesterol conjugates.

Authors:  Awwad A Radwan; Fares K Alanazi
Journal:  Saudi Pharm J       Date:  2013-01-31       Impact factor: 4.330

5.  Novel sugar-cholestanols as anticancer agents against peritoneal dissemination of tumor cells.

Authors:  Shinji Hahismoto; Shin Yazawa; Takayuki Asao; Ahmad Faried; Toyo Nishimura; Kaori Tsuboi; Takashi Nakagawa; Takahito Yamauchi; Noriyuki Koyama; Ken Umehara; Abbi R Saniabadi; Hiroyuki Kuwano
Journal:  Glycoconj J       Date:  2008-03-08       Impact factor: 2.916

6.  ZNF300P1 encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer.

Authors:  Brian Gloss; Kim Moran-Jones; Vita Lin; Maria Gonzalez; James Scurry; Neville F Hacker; Robert L Sutherland; Susan J Clark; Goli Samimi
Journal:  Mol Cancer       Date:  2014-01-06       Impact factor: 27.401

7.  Establishment of a novel method to evaluate peritoneal microdissemination and therapeutic effect using luciferase assay.

Authors:  Ryo Takahashi; Takehiko Yokobori; Katsuya Osone; Hironori Tatsuki; Takahiro Takada; Toshinaga Suto; Reina Yajima; Toshihide Kato; Takaaki Fujii; Souichi Tsutsumi; Hiroyuki Kuwano; Takayuki Asao
Journal:  Cancer Sci       Date:  2016-02-09       Impact factor: 6.716

8.  Inhibition of peritoneal dissemination of colon cancer by hyperthermic CO2 insufflation: A novel approach to prevent intraperitoneal tumor spread.

Authors:  Yuanfei Peng; Hua Yang; Qing Ye; Houming Zhou; Minhua Zheng; Yinghong Shi
Journal:  PLoS One       Date:  2017-02-16       Impact factor: 3.240

9.  A human ex vivo coculture model to investigate peritoneal metastasis and innovative treatment options.

Authors:  Dina Mönch; Jana Koch; Annika Maaß; Nicole Janssen; Thomas Mürdter; Philipp Renner; Petra Fallier-Becker; Wiebke Solaß; Matthias Schwab; Marc-H Dahlke; Hans J Schlitt; Tobias Leibold
Journal:  Pleura Peritoneum       Date:  2021-07-27

10.  Connective tissue growth factor as a novel therapeutic target in high grade serous ovarian cancer.

Authors:  Kim Moran-Jones; Brian S Gloss; Rajmohan Murali; David K Chang; Emily K Colvin; Marc D Jones; Samuel Yuen; Viive M Howell; Laura M Brown; Carol W Wong; Suzanne M Spong; Christopher J Scarlett; Neville F Hacker; Sue Ghosh; Samuel C Mok; Michael J Birrer; Goli Samimi
Journal:  Oncotarget       Date:  2015-12-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.